All Stories

  1. Data from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  2. Figure 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  3. Figure 2 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  4. Figure 3 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  5. Supplementary Figure 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  6. Supplementary Figure 2 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  7. Supplementary Figure 3 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  8. Supplementary Figure 4 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  9. Supplementary Table S1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  10. Table 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  11. Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy

    Article • Cancer Research Communications, July 2025, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  12. Analytical Validation of NavDx+Gyn, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Gynecologic Cancers

    Article • Diagnostics, March 2025, MDPI AG

    Dr. Sunil Kumar

  13. Data from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  14. Data from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  15. Figure S1 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  16. Figure S1 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  17. Figure S2 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  18. Figure S2 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  19. Figure S3 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  20. Figure S3 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  21. Figure S4 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  22. Figure S4 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  23. Supplementary Table ST1 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  24. Supplementary Table ST1 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  25. Supplementary Table ST2 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  26. Supplementary Table ST2 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  27. Supplementary Table ST3 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  28. Supplementary Table ST3 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  29. Supplementary Table ST4 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  30. Supplementary Table ST4 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  31. Supplementary Table ST5 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  32. Supplementary Table ST5 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  33. Supplementary Table ST6 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  34. Supplementary Table ST6 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • April 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  35. Data from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  36. Data from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  37. Figure S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  38. Figure S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  39. Figure S2 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  40. Figure S2 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  41. Figure S3 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  42. Figure S3 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  43. Figure S4 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  44. Figure S4 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  45. Figure S5 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  46. Figure S5 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  47. Table S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  48. Table S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  49. Analytical Validation of NavDx, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Cancers

    Article • Diagnostics, February 2023, MDPI AG

    Dr. Sunil Kumar

  50. Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

    Article • Cancer Research Communications, September 2022, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  51. Targeting ESR1 mutation–induced transcriptional addiction in breast cancer with BET inhibition

    Article • JCI Insight, September 2022, American Society for Clinical Investigation

    Dr. Sunil Kumar

  52. Pre-Treatment Circulating Tumor Human Papillomavirus (HPV) DNA and Recurrence Risk in HPV Associated Malignancy: Oropharyngeal, Anal Canal, and Cervical Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2020, Elsevier

    Dr. Sunil Kumar

  53. Use of Spiked Normalizers to More Precisely Quantify Tumor Markers and Viral Genomes by Massive Parallel Sequencing of Plasma DNA

    Article • Journal of Molecular Diagnostics, April 2020, Elsevier

    Dr. Sunil Kumar

  54. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer

    Article • Journal of Clinical Oncology, April 2020, American Society of Clinical Oncology (ASCO)

    Dr. Sunil Kumar

  55. Detectable HPV ctDNA in Post-Operative Oropharyngeal Squamous Cell Carcinoma Patients is Associated With Progression

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2019, Elsevier

    Dr. Sunil Kumar

  56. Plasma Circulating Tumor HPV DNA for Early Detection of Cancer Recurrence in HPV-associated Oropharyngeal Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, August 2019, Elsevier

    Dr. Sunil Kumar

  57. Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

    Article • Clinical Cancer Research, August 2019, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  58. Multiplexed digital PCR for detection of HPV in tissue samples from oropharyngeal cancer patients.

    Article • Journal of Clinical Oncology, May 2019, American Society of Clinical Oncology (ASCO)

    Dr. Sunil Kumar

  59. Characterization of 4-guanidinobutyrase from Aspergillus niger

    Article • Microbiology, April 2019, Society for General Microbiology

    Dr. Sunil Kumar

  60. Abstract P5-11-09: Feasibility of tracking plasma DNA mutation kinetics in estrogen receptor positive metastatic breast cancer using a novel digital PCR amplicon sequencing assay

    Article • Cancer Research, February 2019, American Association for Cancer Research (AACR)

    Dr. Sunil Kumar

  61. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-associated Oropharyngeal Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, December 2018, Elsevier

    Dr. Sunil Kumar

  62. Tracking plasma DNA mutation dynamics in estrogen receptor positive metastatic breast cancer with dPCR-SEQ

    Article • npj Breast Cancer, December 2018, Springer Science + Business Media

    Dr. Sunil Kumar

  63. HPV-16 ctDNA kinetics predict for pathologic persistent disease in oropharyngeal cancer patients treated with deintensified chemoradiation

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2018, Elsevier

    Dr. Sunil Kumar

  64. Circulating Tumor HPV16 DNA as a Biomarker of Tumor Genomics and Disease Control in HPV-associated Oropharyngeal Squamous Cell Carcinoma

    Article • International Journal of Radiation Oncology*Biology*Physics, April 2018, Elsevier

    Dr. Sunil Kumar

  65. Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer

    Article • Journal of Clinical Investigation, February 2018, American Society for Clinical Investigation

    Dr. Sunil Kumar

  66. Quantification of HPV-16 in Circulating Tumor DNA During De-intensified Chemoradiation Therapy for Favorable-Risk HPV-Associated Oropharyngeal Squamous Cell Carcinoma

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2017, Elsevier

    Dr. Sunil Kumar

  67. Novel Route for Agmatine Catabolism in Aspergillus niger Involves 4-Guanidinobutyrase

    Article • Applied and Environmental Microbiology, June 2015, ASM Journals

    Narayan Punekar, Dr. Sunil Kumar

  68. High-Throughput Screening of Dye-Ligands for Chromatography

    Article • January 2014, Springer Science + Business Media

    Dr. Sunil Kumar

  69. Discriminatory protein binding by a library of 96 new affinity resins: A novel dye-affinity chromatography tool-kit

    Article • Journal of Chromatography B, November 2009, Elsevier

    Dr Kamlesh Pai Fondekar, Dr. Sunil Kumar